News | July 31, 2014

Innovative Data Collection System for Cancer Patients Developed to Improve Care Outcomes

Real-time insights designed to provide personalized approaches for head and neck cancer

July 31, 2014 — An innovative new data collection system could revolutionize the way doctors provide treatment, helping them improve outcomes and decrease side effects for cancer patients, according to research presented at the 56th Annual Meeting of the American Association of Physicists in Medicine (AAPM).

Oncospace is a data mining system designed by medical physicists that collects comprehensive information on head and neck cancer patients to provide guidance in developing high-quality patient-specific therapy. The database contains insights on more than 500 patients and continues to grow.

Radiation therapy protocols are based on clinical trials, but represent care given to fewer than five percent of patients, take years to get results and generally don’t reflect standard practice,” said Todd McNutt, Ph.D., lead author of the study, and associate professor of medical physics and director of clinical informatics in radiation oncology at the Johns Hopkins University School of Medicine, Baltimore. “This system taps into the vast knowledge that exists in data resulting from routine clinical care. It enables us to capture meaningful information in real-time to help design individualized treatment plans and increase the likelihood of success.”

Using Oncospace, healthcare providers continually input information about cancer patients, ranging from family history, medications, surgical procedures and test results to specifics about the tumor (type, stage, size, shape), treatments — including radiation received (dose and target area) — and outcomes. Aggregating the information from all patients, researchers can detect patterns, predict the likelihood of side effects and gather other insights that help them design the best plan for new patients individually.

For example, based on information from 513 head and neck cancer patients, researchers found those who had high doses of radiation to small areas of the larynx, esophagus and muscles of the throat were more likely to have difficulty swallowing, whereas dry mouth was more likely to occur in patients who had lower doses of radiation to larger areas of the salivary glands, inside of the mouth or lower jaw. In new patients, doctors can plan for those side effects — such as by using prophylactic medications or placing a feeding tube before treatment — or lessen or avoid them by revising the radiation treatment plan to minimize the risks.

“The ultimate goal is to use ‘big data’ to provide personalized medicine, meaning for each new patient we’ll have information from the database that can help us predict how well that patient will do, whether he or she is likely to suffer specific side effects and the success of each treatment, and then design the best therapy for that individual,” said McNutt. “The system combines the real-world and ongoing information gathered in a registry with the research-level data collected in a trial.”

The researchers are gathering information on other cancers as well, including pancreas and prostate. The plan is to grow the program and eventually share it with other institutions to compare practices and continually improve treatment.

In addition to McNutt, co-authors of the Oncospace research presented at AAPM are: S. Robertson, H. Quon, A. Kiess, J. Moore, W. Yang, Z. Cheng, and A. Sharabi.

For more information: www.aapm.org

Related Content

Study Unveils Blueprint for Treating Radiation-Resistant Brain Tumor

NIH-funded researchers showed how gliomas may be treated with radiation and drugs that block DNA repair. Image courtesy of Castro lab, Michigan Medicine, Ann Arbor

 

News | Radiation Therapy | February 19, 2019
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by exp
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...
Philips Collaborates With MIM Software on Radiation Therapy Treatment Planning
News | Treatment Planning | January 31, 2019
January 31, 2019 — Philips announced a collaboration with imaging solutions provider MIM Software Inc.
Videos | Lung Cancer | January 29, 2019
Gregory Videtic, M.D., staff physician in radiation oncology at the Cleveland Clinic, and David Johnstone, M.D., prof
Southern Asia's First Proton Therapy Center Begins Treatments
News | Proton Therapy | January 28, 2019
IBA (Ion Beam Applications SA) announced the opening of the Apollo Proton Cancer Centre in Chennai, India, and the...